AIMS/HYPOTHESIS: Pancreatic polypeptide (PP) is produced by the F-cells of the pancreas, and its plasma concentration has been used as a marker of parasympathetic activity. Recent work in rodents suggests that there is both sympathetic and parasympathetic innervation of white adipose tissue and that parasympathetic activity is anabolic resulting in lipid accumulation. We have examined whether in humans increased PP levels are associated with increased intra-abdominal fat (IAF), and thereby insulin resistance. MATERIALS AND METHODS: We measured PP levels in 177 non-diabetic subjects (75 male/102 female; age 32-75 years) 3 min after an i.v. glucose bolus during a frequently sampled intravenous glucose tolerance test. IAF and s.c. fat (SCF) areas were measured by CT scan. The insulin sensitivity index (S (I)) was quantified using Bergman's minimal model. RESULTS: PP levels were higher in men than in women (96.2 +/- 72.2 vs 76.1 +/- 55.0 pg/ml, mean +/- SD, p = 0.037), as was IAF area (124.7 +/- 67.4 vs 83.0 +/- 57.7 cm(2), p < 0.001). While PP levels were significantly associated with IAF (r = 0.16, p = 0.031), WHR (r = 0.30, p < 0.001) and age (r = 0.37, p < 0.01), they were not associated with SCF (r = 0.02, p = 0.829). The association between PP and IAF was not independent of age and/or sex. S(I) was negatively associated with PP levels (r = -0.17, p = 0.026) and IAF area (r = -0.65, p < 0.001). The association between S(I) and PP disappeared after adjusting for IAF area, indicating that S(I) was not a major determinant of PP levels. CONCLUSIONS/ INTERPRETATION: In humans, age and sex may modulate the association between plasma PP level and IAF area, suggesting that they may be determinants of parasympathetic activity and thus IAF accumulation.
AIMS/HYPOTHESIS: Pancreatic polypeptide (PP) is produced by the F-cells of the pancreas, and its plasma concentration has been used as a marker of parasympathetic activity. Recent work in rodents suggests that there is both sympathetic and parasympathetic innervation of white adipose tissue and that parasympathetic activity is anabolic resulting in lipid accumulation. We have examined whether in humans increased PP levels are associated with increased intra-abdominal fat (IAF), and thereby insulin resistance. MATERIALS AND METHODS: We measured PP levels in 177 non-diabetic subjects (75 male/102 female; age 32-75 years) 3 min after an i.v. glucose bolus during a frequently sampled intravenous glucose tolerance test. IAF and s.c. fat (SCF) areas were measured by CT scan. The insulin sensitivity index (S (I)) was quantified using Bergman's minimal model. RESULTS:PP levels were higher in men than in women (96.2 +/- 72.2 vs 76.1 +/- 55.0 pg/ml, mean +/- SD, p = 0.037), as was IAF area (124.7 +/- 67.4 vs 83.0 +/- 57.7 cm(2), p < 0.001). While PP levels were significantly associated with IAF (r = 0.16, p = 0.031), WHR (r = 0.30, p < 0.001) and age (r = 0.37, p < 0.01), they were not associated with SCF (r = 0.02, p = 0.829). The association between PP and IAF was not independent of age and/or sex. S(I) was negatively associated with PP levels (r = -0.17, p = 0.026) and IAF area (r = -0.65, p < 0.001). The association between S(I) and PP disappeared after adjusting for IAF area, indicating that S(I) was not a major determinant of PP levels. CONCLUSIONS/ INTERPRETATION: In humans, age and sex may modulate the association between plasma PP level and IAF area, suggesting that they may be determinants of parasympathetic activity and thus IAF accumulation.
Authors: Felix Kreier; Eric Fliers; Peter J Voshol; Corbert G Van Eden; Louis M Havekes; Andries Kalsbeek; Caroline L Van Heijningen; Arja A Sluiter; Thomas C Mettenleiter; Johannes A Romijn; Hans P Sauerwein; Ruud M Buijs Journal: J Clin Invest Date: 2002-11 Impact factor: 14.808
Authors: Miriam Cnop; Melinda J Landchild; Josep Vidal; Peter J Havel; Negar G Knowles; Darcy R Carr; Feng Wang; Rebecca L Hull; Edward J Boyko; Barbara M Retzlaff; Carolyn E Walden; Robert H Knopp; Steven E Kahn Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: R L Batterham; C W Le Roux; M A Cohen; A J Park; S M Ellis; M Patterson; G S Frost; M A Ghatei; S R Bloom Journal: J Clin Endocrinol Metab Date: 2003-08 Impact factor: 5.958
Authors: M D Esler; A G Turner; D M Kaye; J M Thompson; B A Kingwell; M Morris; G W Lambert; G L Jennings; H S Cox; D R Seals Journal: Am J Physiol Date: 1995-01
Authors: Barbora Vozarova de Courten; Christian Weyer; Norbert Stefan; Mark Horton; Angelo DelParigi; Peter Havel; Clifton Bogardus; P Antonio Tataranni Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Amir H Sam; Michelle L Sleeth; E Louise Thomas; Nurhafzan A Ismail; Norlida Mat Daud; Edward Chambers; Fariba Shojaee-Moradie; Margot Umpleby; Anthony P Goldstone; Carel W Le Roux; Paul Bech; Mark Busbridge; Rosemary Laurie; Daniel J Cuthbertson; Adam Buckley; Mohammad A Ghatei; Stephen R Bloom; Gary S Frost; Jimmy D Bell; Kevin G Murphy Journal: J Clin Endocrinol Metab Date: 2014-12-09 Impact factor: 5.958